VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd is a Canada-based medical device company. The Company is engaged in the development and commercialization of diagnostic tools that monitor patients with heart disease. It is developing a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, imaging, and cardiotoxicity in oncology patients. The Company’s Ventripoint Medical System (VMS+) is a diagnostic aid that was developed to provide a point-of-care solution to better communicate the heart’s structure and function without the need for magnetic resonance imaging (MRI). VMS+ enhances ultrasound, providing three-dimensional (3D) technology that allows for visualization of all four chambers of the heart. The system’s proprietary Knowledge Based Reconstruction (KBR) technology creates 3D models of the heart and calculates volumes and ejection fractions equivalent to the gold-standard Magnetic resonance imaging (MRI).

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > Our relationship with GEHC is strong and growing stronger

<< Previous

Bullboard Posts

Next >>

Post by ScienceFirston Nov 17, 2022 9:21am

122 Views

Post# 35106240

Our relationship with GEHC is strong and growing stronger

The FUD squad tried hard to raise a doubt on our relatioship with GEHC.

It's rather the opposite, as per Dr. Adams's comment this morning.

"Our relationship with GEHC is strong and growing stronger as we await their emergence as a stand-alone company in January 2023 and continue to be part of their Edison digital program."

<< Previous

Bullboard Posts

Next >>

Report: New, more dangerous malware used in increasing cyberattacks